Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Egypt flag Egypt · Delayed Price · Currency is EGP
50.63
-0.36 (-0.71%)
At close: Mar 27, 2025
6.43%
Market Cap 7.53B
Revenue (ttm) 7.59B
Net Income (ttm) 1.10B
Shares Out 148.76M
EPS (ttm) 7.37
PE Ratio 6.87
Forward PE 8.29
Dividend 1.00 (1.98%)
Ex-Dividend Date Apr 28, 2024
Volume 70,960
Average Volume 385,514
Open 50.99
Previous Close 50.99
Day's Range 50.04 - 51.50
52-Week Range 32.23 - 54.70
Beta 0.43
RSI 62.68
Earnings Date May 25, 2025

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company offers analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolic; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It also exports its products. Egyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based i... [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol PHAR
Full Company Profile

Financial Performance

In 2024, EGX:PHAR's revenue was 7.59 billion, an increase of 45.09% compared to the previous year's 5.23 billion. Earnings were 1.10 billion, an increase of 33.25%.

Financial Statements

News

There is no news available yet.